DE68912263D1 - 4-Methyl-5[2-(4-phenyl-1-piperazinyl)-ethyl]-Thiazolderivate, ihre Herstellung und Zusammenstellungen, die sie enthalten. - Google Patents
4-Methyl-5[2-(4-phenyl-1-piperazinyl)-ethyl]-Thiazolderivate, ihre Herstellung und Zusammenstellungen, die sie enthalten.Info
- Publication number
- DE68912263D1 DE68912263D1 DE89402781T DE68912263T DE68912263D1 DE 68912263 D1 DE68912263 D1 DE 68912263D1 DE 89402781 T DE89402781 T DE 89402781T DE 68912263 T DE68912263 T DE 68912263T DE 68912263 D1 DE68912263 D1 DE 68912263D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- derivatives
- phenyl
- ethyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- ADUBJHQJHAAFNC-UHFFFAOYSA-N 4-methyl-5-[2-(4-phenylpiperazin-1-yl)ethyl]-1,3-thiazole Chemical class N1=CSC(CCN2CCN(CC2)C=2C=CC=CC=2)=C1C ADUBJHQJHAAFNC-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 206010013990 dysuria Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002820 sympathetic nervous system Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8813375A FR2637596B1 (fr) | 1988-10-11 | 1988-10-11 | Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68912263D1 true DE68912263D1 (de) | 1994-02-24 |
DE68912263T2 DE68912263T2 (de) | 1994-06-01 |
Family
ID=9370913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68912263T Expired - Fee Related DE68912263T2 (de) | 1988-10-11 | 1989-10-10 | 4-Methyl-5[2-(4-phenyl-1-piperazinyl)-ethyl]-Thiazolderivate, ihre Herstellung und Zusammenstellungen, die sie enthalten. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5120736A (de) |
EP (1) | EP0364350B1 (de) |
JP (1) | JPH04501263A (de) |
AT (1) | ATE100092T1 (de) |
CA (1) | CA2000247A1 (de) |
DE (1) | DE68912263T2 (de) |
DK (1) | DK168861B1 (de) |
FR (1) | FR2637596B1 (de) |
WO (1) | WO1990003972A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2637596B1 (fr) * | 1988-10-11 | 1992-09-04 | Irceba | Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant |
FR2658514B1 (fr) * | 1990-02-19 | 1992-06-19 | Irceba | Nouveaux derives du methyl-4 thiazole, leurs procedes de preparation et les compositions pharmaceutiques en contenant. |
US5512677A (en) * | 1991-08-13 | 1996-04-30 | National Science Council | 3-substituted methyl-2,3-dihydroimidazo 1,2-c!quinazoline derivatives, the preparation and use thereof |
US5158953A (en) * | 1991-08-13 | 1992-10-27 | National Science Council | 2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof |
US5474994A (en) * | 1992-05-26 | 1995-12-12 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A |
US5605896A (en) * | 1992-02-25 | 1997-02-25 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities |
IT1254469B (it) * | 1992-02-25 | 1995-09-25 | Recordati Chem Pharm | Derivati benzopiranici e benzotiopiranici |
IT1258315B (it) * | 1992-04-10 | 1996-02-22 | Recordati Chem Pharm | Derivati del flavone |
WO1995026955A1 (fr) | 1994-03-30 | 1995-10-12 | Zeria Pharmaceutical Co., Ltd. | Derive d'indole et medicament le contenant |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1595923A1 (de) * | 1965-02-20 | 1969-11-27 | Merck Ag E | 1-Aralkyl-4-(thiazolyl-2)-piperazine und Verfahren zu ihrer Herstellung |
FR2594335B1 (fr) * | 1986-02-14 | 1991-09-13 | Irceba | Derives de 5-(2-piperazinoethyl)-thiazole en tant que medicaments utiles en urologie |
FR2637596B1 (fr) * | 1988-10-11 | 1992-09-04 | Irceba | Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant |
DE3923675A1 (de) * | 1989-07-18 | 1991-01-24 | Basf Ag | Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel |
-
1988
- 1988-10-11 FR FR8813375A patent/FR2637596B1/fr not_active Expired - Lifetime
-
1989
- 1989-10-06 CA CA002000247A patent/CA2000247A1/fr not_active Abandoned
- 1989-10-10 US US07/671,719 patent/US5120736A/en not_active Expired - Fee Related
- 1989-10-10 EP EP89402781A patent/EP0364350B1/de not_active Expired - Lifetime
- 1989-10-10 WO PCT/FR1989/000520 patent/WO1990003972A1/fr unknown
- 1989-10-10 JP JP1511513A patent/JPH04501263A/ja active Pending
- 1989-10-10 DE DE68912263T patent/DE68912263T2/de not_active Expired - Fee Related
- 1989-10-10 AT AT89402781T patent/ATE100092T1/de active
-
1991
- 1991-04-10 DK DK064191A patent/DK168861B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0364350B1 (de) | 1994-01-12 |
DE68912263T2 (de) | 1994-06-01 |
ATE100092T1 (de) | 1994-01-15 |
CA2000247A1 (fr) | 1990-04-11 |
DK64191D0 (da) | 1991-04-10 |
EP0364350A1 (de) | 1990-04-18 |
FR2637596A1 (fr) | 1990-04-13 |
JPH04501263A (ja) | 1992-03-05 |
WO1990003972A1 (fr) | 1990-04-19 |
DK168861B1 (da) | 1994-06-27 |
FR2637596B1 (fr) | 1992-09-04 |
US5120736A (en) | 1992-06-09 |
DK64191A (da) | 1991-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95108329A (ru) | Замещенные производные тиазолидиндиона, способ их получения, фармкомпозиция | |
ZA92504B (en) | Use of w-4-(2,pyrimidinyl)-1-piperazinyl alkyl-1h-azole derivatives for the preparation of medicinal products intended for the treatment of disorders of cognitive functions | |
KR910004581A (ko) | 신규 화합물들 | |
DE3567023D1 (en) | Diphosphonic-acid derivatives, process for their preparation and medicines containing them | |
KR910004580A (ko) | 신규 화합물 | |
KR940000447A (ko) | 티아졸의 분지쇄 알킬아미노유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물 | |
DE69230163D1 (de) | Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten | |
AU638979B2 (en) | New benzylcyclanone derivatives, process for preparing them and cosmetic and pharmaceutical compositions containing them | |
DE68912263T2 (de) | 4-Methyl-5[2-(4-phenyl-1-piperazinyl)-ethyl]-Thiazolderivate, ihre Herstellung und Zusammenstellungen, die sie enthalten. | |
KR880001642A (ko) | 7-아실옥시-6-아미노 아실옥시폴리옥시라브단, 그의 제조방법 및 약제로서의 용도 | |
KR937000438A (ko) | 3-인돌릴 티오아세테이트 유도체 | |
ATE8144T1 (de) | Indolobenzoxazine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen. | |
KR940007020A (ko) | 피레리딘 유도체, 이것의 제법 및 이것의 치료에의 이용 | |
DE3070227D1 (en) | Benzothiazole derivatives, pharmaceutical compositions containing them and process for their preparation | |
ATE11912T1 (de) | ((indol-3-yl)-3-amino-2-propionyloxy)-2essigs|urederivate, verfahren zu ihrer herstellung und heilmittel, die sie enthalten. | |
ATE89276T1 (de) | ((aryl-4-piperazinyl-1)-2-ethoxy>-3p-cymole, die ortho-, meta-, para-monosubstituierten oder disubstituierten derivate, das verfahren zu deren herstellung und die als aktives prinzip diese verbindungen enthaltenden arzneimittel. | |
EP0112587A3 (en) | Derivatives of 4-(1-(phenyl)-1-(hydroxy)-prop-1-yl)-resorcine, process for their preparation and medicines containing these compounds | |
ZA881383B (en) | 2-(2,3-dihydro-2-oxo-3-benzofuranyl)acetic acid derivatives,processes for preparing them and the pharmaceutical compositions which contain them | |
DE3866603D1 (de) | 1-benzoyl-2-oxo-5-alkoxy-pyrrolidin-derivate, ihre herstellung und verwendung als heilmittel und zubereitungen, die sie enthalten. | |
NZ238431A (en) | ((1-arylpyrrolidin-2-yl)methyl)piperazine derivatives; pharmaceutical compositions and preparatory processes | |
AU591255B2 (en) | New derivatives of 1-styrenesulphonyl-2-oxo-5-hydroxy pyrrolidine, the process and the intermediates for their preparations, their application as medicaments and the compositions containing them | |
ES8608509A1 (es) | Procedimiento para preparar nuevos derivador de 2-(1-imidazolil)-etanol | |
DE3860117D1 (de) | 2,3-dihydro-3-phenyl-benzofuran-2-on-acetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |